Tegaserod: all 23 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic ConstipationTerminatedNCT00563758Not applicable
- Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic MethodStatus unknownNCT00563615Not applicable
- Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.TerminatedNCT00414024Phase 3
- Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.TerminatedNCT00399659Phase 3
- Effect of Tegaserod on Gastric Emptying in Patients With Diabetic GastroparesisTerminatedNCT00390975Phase 4
- Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer PainTerminatedNCT00365820Phase 2/3
- Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation PatientsTerminatedNCT00348634Phase 4
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232102Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232089Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232037Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232024Phase 3
- Preference of Tegaserod vs. PEG 3350 in Patients With ConstipationCompletedNCT00171522Phase 4
- Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171483Phase 3
- The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.CompletedNCT00171470Phase 3
- The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.CompletedNCT00171457Phase 3
- The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)TerminatedNCT00171431Phase 3
- Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171418Phase 3
- Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic ConstipationCompletedNCT00149877Phase 4
- A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00149851Phase 2
- Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBSCompletedNCT00142987Phase 4
- Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic GastropathyTerminatedNCT00142974Phase 2
- Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.CompletedNCT00141089Phase 3
- An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic ConstipationCompletedNCT00139568Phase 3